German Life Sciences Trend Analysis 2016

2015 was a quiet year in terms of the emergence of new private German biotech companies but in terms of financing, the 12 months remained steady. That being said it was not enough to match the high of the latter half of 2014, where USD 247.5m was raised.

Read the full report below.

German LS Trend Analysis 2016